𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical review of Crohn’s disease

✍ Scribed by Brenda Ruthruff

Book ID
111359317
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
77 KB
Volume
19
Category
Article
ISSN
1041-2972

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and clinical significance of i
Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: A critical systematic review
✍ Andrea Cassinotti; Simon Travis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Background: Infliximab (IFX) is a chimeric (mouse/human) anti-TNF-alpha monoclonal antibody approved for the treatment of refractory luminal and fistulizing Crohn's disease (CD). It is a source of potential immunogenicity for humans, with the occurrence of anti-infliximab antibodies (ATIs), which ar